To assess the risk of lung cancer in patients with chronic obstructive pulmonary disease, we matched, on the basis of age, sex, occupation, and smoking history, 113 persons ("cases") who had a forced expiratory volume in 1 second (FEV1) of 70% or less of predicted normal with 113 control persons who had an FEV1 of 85% or more. All persons were observed from 1973-74 through 1984 for a diagnosis of lung cancer, death from lung cancer, and death from any cause. At entry, subjects had an age range of 45 to 59 years; men numbered 186 and women 40. Histologically proven lung cancer developed in 9 cases and in 2 controls, all men. The rate of development of lung cancer was significantly different in the two groups (p = 0.024): the 10-year cumulative percentage was 8.8% for cases and 2.0% for controls. Overall 10-year survival was estimated to be 74.0% for cases and 91.1% for controls (p less than 0.001).
The broad spectrum of clinical manifestations seen in certain infectious diseases often mimics the protean aspects of chronic inflammatory disorders. The frequent lack of specific clinical and laboratory features of a rheumatic disease, such as systemic lupus erythematosus (SLE), may cause confusion in the diagnostic process. We describe a patient who has secondary syphilis and shows signs and symptoms compatible with SLE.Case report. A 36-year-old white man presented with complaints of fevers and arthralgias of 2 months' duration. He noted a sore throat, low-grade fever, and low backache at the onset of symptoms. His private physician performed a throat culture the results of which were negative for P-streptococcus, and aspirin was prescribed.Over the intervening 2 months, the patient noted persistent diffuse arthralgias which were maximal in the wrists and knees and accompanied by morning stiffness. Intermittent fever to 39°C ensued. Small scales developed on the scalp, followed by patchy hair loss. Several small circular breaks in the skin were noted, as were two sores on the inner lower lip and gum. He reconsulted his private physician who performed laboratory tests that showed erythrocyte sedimentation rate (ESR) > 100 mm/hour and antinu- clear antibodies positive at 1 :80. A diagnosis of systemic lupus erythematosus was made, and conservative therapy with salicylates was begun.Because of his subsequent failure to improve while on this regimen, the patient was referred to Mayo Clinic by his local physician for consideration of additional treatment. Review of his history revealed an episode of hepatitis with jaundice. There was no history of pleurisy, photosensitivity, or Raynaud's phenomenon. Sexual preference was homosexual with several partners. He denied having previous genital lesions or known venereal disease.At the time of physical examination he was afebrile. Patchy hair loss was seen on the scalp ( Figure 1) along with alopecia of the pubis. Small ulcers were noted inside the lips. Scattered cervical, postauricular, and inguinal nodes were palpable. No active synovitis or splenomegaly was evident, and genital examination was unremarkable.Blood tests revealed hemoglobin of 10.8 gm/dl (mean cell volume 88.0p3), white blood cell count of 4,3OO/pl, and ESR 108 mm/hour. A peripheral smear showed mild aniswytosis and rouleaux formation. Serum protein electrophoresis included a gamma globulin count of 2.33 gm/dl. A blood chemistry profile, complement studies, fluorescent antinuclear antibody, anti-native DNA antibody, and test for rheumatoid factor were negative or normal. However, the hepatitis B surface antigen test was positive, and the syphilis serology test using the ART system (Technicon Instrument Corp., Tarrytown, NY) was reactive at 1:64 dilution.The diagnosis of syphilis was suspected, and a fluorescent treponemal antibody absorption (FTA-ABS) test for syphilis was 4 + reactive. Oral, rectal,
A patient who had recently undergone craniotomy for a meningioma experienced carbamazepine (Tegretol)-induced hemolytic anemia. To our knowledge, this is the first reported case of hemolytic anemia clearly induced by carbamazepine.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.